Stock Quote

Symbol:   Go

Register to Vote & Comment
ipb_freeEletter_btn.gif
rss feed

To add an specific blogger's feed, simply go to their blog and click on their individual RSS link.

Cepheid (CPHD): A False Hit Based on a False Claim

Before you read this post, please know that I do not own this stock, although I do recommend it in my service. I'm exposing this because it's a hatchet job done on a product category that can save tens-of-thousands of lives -- and because a company's stock took a hit for no reason.

That company, Cepheid (CPHD), took a major hit yesterday after the close, due to an article in the Journal of the American Medical Association -- an article that should never have been published.

If it was vetted, then the people who agreed to its publication should check into a hospital that doesn't do any MRSA testing the next time they aren't well.

The article claimed that MRSA testing did not help reduce MRSA infections -- which of course is not only illogical but utter nonsense if you live in the real world.

Find out all the reasons the drop in Cepheid was unjustified.


Post a comment


You must be logged in to comment. Click here to register.


You are signed in as .



Comment Preview

Preview your comment here

Financial Market Data powered by Quotemedia.com. All rights reserved. Terms and conditions.
NYSE/AMEX data delayed 20 minutes. NASDAQ/other data delayed 15 minutes unless indicated.

Advertise With Us
Copyright © 2008 InvestorPlace Media, LLC. All rights reserved.
700 Indian Springs Drive, Lancaster, PA 17601